drug interaction(s) of SGLT-2 inhititor (flozin) in combination with GLP1-agonist
Jump to navigation
Jump to search
Drug interactions
- GLP-1 agonists (incretin mimetics) & SGLT-2 inhititor (flozin) have additive benefits for cardiovascular disease & diabetic nephropathy[1]
More general terms
References
- ↑ 1.0 1.1 Simms-Williams N et al. Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: Population based cohort study. BMJ 2024 Apr 25; 385:e078242. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38663919 PMCID: PMC11043905 Free PMC article https://www.bmj.com/content/385/bmj-2023-078242